Drugs News and Research

RSS

Hospira’s net sales increase 6.3% to $1.1B in first quarter 2014

Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, today reported results for the first quarter ended March 31, 2014.

30 Apr 2014

Otonomy secures $49M in oversubscribed Series D round of financing

Otonomy, Inc., a biopharmaceutical company developing and commercializing innovative therapeutics for diseases and disorders of the inner and middle ear, today announced it has secured $49 million in an oversubscribed Series D round of financing.

30 Apr 2014

Viewpoints: New poll points out inconsistencies among health law's opponents; protecting vets; Calif. restaurant nutrition info missing

The case against the Affordable Care Act rests on the premise that the free market can better provide health insurance to the nation's 54 million uninsured than a government program can. But what does it mean if many of the same people who oppose Obamacare also object to the cost of covering more people through the market? A telephone survey by Bankrate.com asked 3,496 people how they would react if a business tacked on an extra 25 cents to every bill to help cover the cost of health insurance for its employees. Among Democrats, 70 percent said they would approve.

30 Apr 2014

Otsuka's Deltyba gets EC marketing authorization for MDR-TB treatment

Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.

30 Apr 2014

Mother's diet before conception can permanently affect how her child's genes function

A mother's diet before conception can permanently affect how her child's genes function, according to a study published in Nature Communications.

30 Apr 2014

Washington state requires insurers to spell out networks

The insurance commissioner issued controversial rules mandating that insurers explain referral and authorization practices to consumers. Meanwhile, a study details how nearly half the plans available through federal and state exchanges didn't list what drugs patients had access to on their websites and Politico Pro questions whether more states will join the federal exchange.

30 Apr 2014

Researchers develop new strategy to personalised medicine in advanced cancer patients

Tumour cells can accumulate hundreds or even thousands of DNA mutations which induce the growth and spread of cancer. The number and pattern of mutations differs according to the type of tumour, even among those that are classified as part of the same type of tumours.

30 Apr 2014

Researchers demonstrate possibility of using blood test to detect depression

Researchers at the MedUni Vienna have demonstrated the possibility of using a blood test to detect depression. While blood tests for mental illnesses have until recently been regarded as impossible, a recent study clearly indicates that, in principle, depression can in fact be diagnosed in this way and this could become reality in the not too distant future.

30 Apr 2014

GE Healthcare announces commercial availability of new Alzheimer’s diagnostic tool

GE Healthcare today announced the first seven markets where Vizamyl (Flutemetamol F18 injection), a radioactive diagnostic agent approved by the FDA will be available. Late in the second quarter of 2014, Vizamyl will be available to imaging centers near East Rutherford, NJ, Woburn, MA, Beltsville, MD, East Lansing, MI, Dallas, TX, Phoenix, AZ and Colton, CA.

29 Apr 2014

Can-Fite BioPharma submits study protocol to FDA for CF102 Phase II trial for advanced liver cancer

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that it has submitted a study protocol to the U.S. Food and Drug Administration for its Phase II clinical trial of CF102 for the treatment of advanced liver cancer.

29 Apr 2014

Armetheon reaches agreement with FDA on SPA for final pivotal trial of tecarfarin

Armetheon, Inc., today announced that it has reached agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) for the final pivotal trial of tecarfarin.

29 Apr 2014

Scientists at Sheffield Hallam University receive major funding boost for animal-testing reduction project

Almost a quarter of a million pounds has been awarded to a team of scientists at Sheffield Hallam University to develop a new technique that will reduce the need for animal testing in pre-clinical research projects.

From Sheffield Hallam University 29 Apr 2014

Adhesion molecule offers promising therapeutic target for preventing colitis

May Provide Therapeutic Target for Treating Inflammatory Bowel Disease and Preventing Colitis-Associated Colorectal Cancer, According to New Research Published in The American Journal of Pathology

29 Apr 2014

The rising incidence of multi-drug resistant TB: an interview with Dr Myriam Haxaire-Theeuwes, Compound Development Team Leader, Janssen

MDR-TB is on the rise in a number of regions in the world, because progress towards targets for diagnosis and treatment of multidrug-resistant TB (MDR-TB) is far off-track.

29 Apr 2014

Teva's DuoResp Spiromax receives EC marketing authorization for treatment of asthma, COPD

Teva Pharmaceutical Industries Ltd., announced today that the European Commission has granted marketing authorization for DuoResp Spiromax for the treatment of patients with asthma and chronic obstructive pulmonary disease (COPD) where the use of a combination of an inhaled corticosteroid and long-acting beta2-adrenoceptor agonist is appropriate.

29 Apr 2014

People who take statin drugs develop heart disease and obesity-related illnesses

People who take statin drugs to lower their cholesterol appear to have developed a false sense of security that could lead to heart disease and other obesity-related illnesses.

29 Apr 2014

Viewpoints: Boehner's 'truthful gaffe' on health law; Larry Kramer's AIDS crusade; costly drugs

Although "repeal and replace" has been the Republican position on Obamacare since 2010, "replace" has been there mainly because it polled well. Republicans were satisfied with the health-care status quo in 2009, and would have been glad to repeal Obamacare to return to it. As Steve Benen points out, Republicans voted for just-plain-repeal many times.

29 Apr 2014

Studies demonstrate new approaches to treating and preventing Parkinson's disease

A trio of studies from the Perelman School of Medicine at the University of Pennsylvania demonstrate new approaches to understanding, treating and potentially staving off Parkinson's disease (PD). Studies show that factors such as estrogen exposure and statin use have an impact on the onset of Parkinson's disease.

29 Apr 2014

Scientists identify first gene linked to childhood-onset familial dilated cardiomyopathy

Scientists at Icahn School of Medicine at Mount Sinai, along with collaborators at institutions in India, Italy, and Japan, have identified the first gene linked to childhood-onset familial dilated cardiomyopathy (DCM), one of the most common heart muscle diseases in children.

29 Apr 2014

GSK, Theravance announce availability of Anoro Ellipta in the US for COPD treatment

GlaxoSmithKline plc and Theravance, Inc. today announced that Anoro Ellipta (umeclidinium and vilanterol inhalation powder), the first once-daily product approved in the US that combines two long-acting bronchodilators in a single inhaler for the maintenance treatment of chronic obstructive pulmonary disease (COPD), is now available to retail pharmacies in the US.

28 Apr 2014

Drugs News and Research

Hospira’s net sales increase 6.3% to $1.1B in first quarter 2014

Otonomy secures $49M in oversubscribed Series D round of financing

Viewpoints: New poll points out inconsistencies among health law's opponents; protecting vets; Calif. restaurant nutrition info missing

Otsuka's Deltyba gets EC marketing authorization for MDR-TB treatment

Mother's diet before conception can permanently affect how her child's genes function

Washington state requires insurers to spell out networks

Researchers develop new strategy to personalised medicine in advanced cancer patients

Researchers demonstrate possibility of using blood test to detect depression

GE Healthcare announces commercial availability of new Alzheimer’s diagnostic tool

Can-Fite BioPharma submits study protocol to FDA for CF102 Phase II trial for advanced liver cancer

Armetheon reaches agreement with FDA on SPA for final pivotal trial of tecarfarin

Scientists at Sheffield Hallam University receive major funding boost for animal-testing reduction project

Adhesion molecule offers promising therapeutic target for preventing colitis

The rising incidence of multi-drug resistant TB: an interview with Dr Myriam Haxaire-Theeuwes, Compound Development Team Leader, Janssen

Teva's DuoResp Spiromax receives EC marketing authorization for treatment of asthma, COPD

People who take statin drugs develop heart disease and obesity-related illnesses

Viewpoints: Boehner's 'truthful gaffe' on health law; Larry Kramer's AIDS crusade; costly drugs

Studies demonstrate new approaches to treating and preventing Parkinson's disease

Scientists identify first gene linked to childhood-onset familial dilated cardiomyopathy

GSK, Theravance announce availability of Anoro Ellipta in the US for COPD treatment

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News